-+ 0.00%
-+ 0.00%
-+ 0.00%

*Larimar Therapeutics Has $244.5M in Cash, Cash Equivalents and Marketable Securities as of Dec 31, With Projected Cash Runway Into 2Q of 2027 >LRMR

Dow Jones·03/19/2026 11:01:00

Please log in to view news